by Mark Bunting | Nov 24, 2020 | Big Picture, E-Commerce, Healthcare, Interviews, Investing, Stocks, Videos
Investor money will flow back and forth the next several months from reopening stocks to stay-at-home stocks depending on the pace of the virus and vaccine distribution. That’s according to John Johnston, EVP & Chief Strategist at Davis Rea Investment...
by Uncommon Sense Investor | Nov 16, 2020 | Blogs, Disruption, E-Commerce, Healthcare, Investing, Media, Stocks, Technology
Altimetry describes itself as a boutique financial research and publishing firm providing individual investors with unique, unbiased investment recommendations and analytics. Anthony Scilipoti, President & CEO, Veritas Investment Research, turned us on to them and...
by Mark Bunting | Nov 13, 2020 | Big Picture, Canada, Healthcare, Interviews, Investing, Stocks, United States, Videos
John Johnston has some very informed and definite thoughts on what political gridlock in the U.S. means for investors. The Chief Strategist of Davis Rea Investment Counsel also has insights in this video on the prospects for COVID-19 vaccines and the unanswered...
by Mark Bunting | Nov 13, 2020 | Big Picture, Blogs, Disruption, Healthcare, Investing, Stocks, Technology
Even though we’ve all become epidemiology experts over the past several months, Peter Berezin walks the walk. The Chief Global Strategist at BCA Research earned a Master of Science from the London School of Economics back in the day so his insights into possible...
by Mark Bunting | Nov 13, 2020 | Banking, Big Picture, Canada, Financial Planning, Healthcare, Interviews, Investing, Stocks, Technology, Videos
Here’s one vote for value stocks. Peter Berezin has waded into the debate about whether investors should start reducing their exposure to big technology growth companies and start putting money into the type of stocks that have been clobbered by the pandemic....
by Uncommon Sense Investor | Nov 12, 2020 | Big Picture, Blogs, Disruption, E-Commerce, Financials, Healthcare, Investing, Stocks, Technology
A debate is raging about whether we’re in the midst of a major shift, years in the making, from growth stocks to value stocks, now that a COVID-19 vaccine appears to be on the horizon. Some market participants say the time is now to buy inexpensive stocks...
